Nasdaq Sell-Off: This Magnificent Stock Is a Bargain Buy

Date:

Share post:


ywAAAAAAQABAAACAUwAOw==

The Nasdaq stock market has officially entered correction territory, with the Nasdaq Composite (NASDAQINDEX: ^IXIC) down by about 14% from its recent high as I write this. While the recent volatility can certainly be scary, it can also create buying opportunities for patient long-term investors.

One stock that looks especially interesting is banking disruptor SoFi Technologies (NASDAQ: SOFI). Despite entering 2025 with excellent momentum, the stock has lost more than a third of its value in the past six weeks, and this could be a great time for investors to take a closer look.

I won’t sugarcoat it: SoFi’s stock chart looks scary. But if we ignore SoFi’s stock price performance for a bit and simply look at how its business is performing, it paints a much different picture.

In 2024, SoFi grew its revenue by 26% to an all-time high, and produced the highest adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA); adjusted earnings per share (EPS); and net income in its history. Although it is still very much in growth mode, this was the company’s first full year of profitability, and while SoFi certainly trades for a premium to its peers, the bank grew its tangible book value by a staggering 39% in 2024.

SoFi ended 2024 with 10.1 million members, 34% more than it had at the end of the prior year. It reached $25 billion in deposits, an especially impressive milestone considering SoFi didn’t have a banking charter until 2022.

Plus, SoFi is growing in ways that could pay off handsomely in the long run. It is rapidly scaling its loan platform business, which originates loans on behalf of third-party lenders, and also makes referrals, creating a low-risk, capital-light source of fee income. Furthermore, the Galileo technology platform’s growth is accelerating, and it recently signed a processing deal for the Direct Express federal benefits program.

Credit cards are another area to watch. SoFi launched two new credit cards in the fourth quarter, the SoFi Everyday Cash Rewards and SoFi Essential. Both are solid products, and there could be many others to come.

For example, SoFi has a rather affluent membership base, so a premium-style credit card product or a travel credit card could resonate with its members. The high-interest nature of credit cards can create some attractive margins, so I’m excited to see this part of the business evolve.

Looking ahead, SoFi anticipates revenue growth of about 25% in 2025, and diluted EPS growth of about 73%. And keep in mind that this is a company with a strong history of overdelivering on its guidance.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

This 'Dune' isn't fiction. It's the longest conveyer belt in the US and moving sand in Texas

KERMIT, Texas (AP) — It's longer than the width of Rhode Island, snakes across the oil fields...

Trump said Russia had ‘all the cards,’ but this ceasefire proposal just called Putin’s bluff

With Ukraine signed up to US proposals for a 30-day ceasefire, the pressure is now on the...

Scott Peterson injured in prison | Banfield

California inmate Scott Peterson was injured at Mule Creek State Prison on Sunday, state officials said. The...

USAID staff ordered to shred and torch records as Trump is named in emergency court motion

A senior official with the U.S. Agency for International Development, which has been targeted for death by...

Musk launches appeal to restore $56 billion Tesla payday

By Tom Hals WILMINGTON, Delaware (Reuters) - Elon Musk kicked off his appeal to...

Kennedy tells US food companies to remove artificial dyes

By Jessica DiNapoliNEW YORK (Reuters) -U.S. Health Secretary Robert F. Kennedy Jr. told food companies including PepsiCo...

Researchers are learning the Trump administration axed their work to improve vaccination

WASHINGTON (AP) — The Trump administration is canceling studies about ways to improve vaccine trust and access,...